Adaptimmune Therapeutics PLC (ADAP)

0.5912 -0.18 (-23.28%) USD  |  NASDAQ  |  Nov 14, 16:00
0.60 +0.01 (+1.49%) After-Hours: 20:00
More

Adaptimmune Therapeutics EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for ADAP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted from Other Gain/Loss (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Biodexa Pharmaceuticals PLC --
Verona Pharma PLC --
NuCana PLC --
Autolus Therapeutics PLC --
Bicycle Therapeutics PLC --